Skip to content

Regeneron Pharmaceuticals

US · REGN #285 by market cap Listed 1970
920.69 -1.71 -0.19%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
B+
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
2 3
■ Upgrades■ Downgrades
  • 2 upgrades vs 3 downgrades among tracked analyst rating changes.
  • Most recent: UBS moved from Hold to Buy on 2026-10-14.

Analyst consensus 23 analysts

Buy
Avg price target 959.57 +4.2%
Price target rangecurrent 920.69
Low761.00
Avg959.57
High1,175.00
Buy 70% Hold 30% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-02 CCORF -- Buy 1,175.00
2026-11-02 UBS -- Buy 1,068.00
2026-11-02 Truist Financial -- Buy 982.00
2026-11-02 BMO Capital -- Buy 1,050.00
2026-11-02 Guggenheim -- Buy 1,100.00
2026-11-02 Leerink Partners -- Hold 997.00
2026-11-01 Cantor Fitzgerald -- Buy 980.00
2026-10-30 Wells Fargo -- Hold 925.00
2026-10-30 Piper Sandler -- Buy 1,000.00
2026-10-30 Raymond James -- Buy 1,020.00
2026-10-30 BofA Securities -- Buy 1,030.00
2026-10-30 Morgan Stanley -- Hold 855.00
2026-10-30 Citi -- Hold 825.00
2026-10-30 RBC Capital -- Hold 913.00
2026-10-30 J.P. Morgan -- Buy 1,050.00
2026-10-28 CCORF -- Buy 922.00
2026-10-27 RBC Capital -- Hold 810.00
2026-10-21 TD Cowen -- Buy 980.00
2026-10-21 Leerink Partners -- Hold 835.00
2026-10-20 Leerink Partners -- Hold 835.00
2026-10-19 Piper Sandler -- Buy 865.00
2026-10-16 UBS -- Buy 978.00
2026-10-15 UBS -- Buy 978.00
2026-10-14 UBS -- Buy 978.00
2026-10-14 Scotiabank -- Hold 770.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-10-14 UBS Hold → Buy 978.00
2026-08-17 Leerink Partners Buy → Hold 824.00
2026-05-17 Citi Buy → Hold 700.00
2026-01-07 BofA Securities Sell → Buy 860.00
2025-12-03 Morgan Stanley Buy → Hold 767.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-10-30 -- ±5.70% +13.33% (beat)
2026/Q2 2026-07-30 -- ±5.74% +6.17% (beat)
2026/Q1 2026-04-29 -- ±6.78% -6.21% (in line)
2025/Q4 2026-01-30 -- ±6.18% -1.07% (in line)
2025/Q3 2025-10-28 -- ±5.28% +11.82% (beat)
2025/Q2 2025-08-01 -- ±8.36% +2.46% (in line)
2025/Q1 2025-04-29 -- ±5.87% -6.87% (beat)
2024/Q4 2025-02-04 -- ±5.57% +4.53% (in line)
2024/Q3 2024-10-31 -- ±3.92% -9.17% (beat)
2024/Q2 2024-08-01 -- ±4.99% +1.29% (in line)
2024/Q1 2024-05-02 -- ±4.24% +3.78% (in line)
2023/Q4 2024-02-02 -- ±3.84% -1.32% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:42 · For reference only, not investment advice and not tailored to your situation.

Regeneron Pharmaceuticals discussion 0 comments

Add a comment